Optiver Holding’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-103
Closed -$9.51K 2892
2026
Q1
$9.51K Sell
103
-139
-57% -$14K ﹤0.01% 1221
2025
Q4
$24.7K Sell
242
-526
-68% -$47.1K ﹤0.01% 994
2025
Q3
$48K Buy
768
+465
+153% +$25.3K ﹤0.01% 789
2025
Q2
$15.8K Buy
+303
New +$13.5K ﹤0.01% 891
2025
Q1
Sell
-298
Closed -$9.1K 1436
2024
Q4
$9.1K Buy
+298
New +$8.38K ﹤0.01% 773
2024
Q3
Sell
-401
Closed -$11.6K 1004
2024
Q2
$11.6K Buy
+401
New +$9.34K ﹤0.01% 696
2022
Q2
Sell
-180
Closed -$12K 418
2022
Q1
$12K Buy
+180
New +$12.3K ﹤0.01% 420

Other funds holding GH

Optiver Holding's GH Position: Q2 2026 in Review

Optiver Holding sold out of Guardant Health (GH) in Q2 2026, closing a stake of 103 shares — an estimated $9.51K sold.

Optiver Holding first reported a position in GH in Q1 2022 and held it in 7 quarters. The position peaked at $48K in Q3 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Optiver Holding reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 103 Guardant Health shares in Q2 2026, an estimated $9.51K.
  • Optiver Holding first reported a position in Guardant Health in Q1 2022 and held it in 7 quarters.
  • Optiver Holding's Guardant Health position peaked at $48K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.